Jeff Yass’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
BBA
Jeff Yass's GLUE Position: Q3 2026 in Review
Jeff Yass increased its Monte Rosa Therapeutics (GLUE) stake by 425% in Q3 2026, buying an estimated $2.5M and bringing the position to 179,915 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #6104.
Jeff Yass first reported a position in GLUE in Q2 2022 and has held it in 12 quarters since. 190 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Jeff Yass held 179,915 shares of Monte Rosa Therapeutics worth $2.15M as of Q3 2026.
- Jeff Yass bought 145,634 Monte Rosa Therapeutics shares in Q3 2026, an estimated $2.5M.
- Monte Rosa Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6104 holding.
- Jeff Yass first reported a position in Monte Rosa Therapeutics in Q2 2022 and has held it in 12 quarters since.
- 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.